Carlos Cruchaga
@ccrugom
NeuroGenomics and Informatics Center Director.
Washington University School of Medicine
ID: 481753989
https://cruchagalab.wustl.edu 03-02-2012 04:17:21
869 Tweet
1,1K Takipçi
338 Takip Edilen
Extremely excited to finally announce I'm starting my own lab on October 1st at the NeuroGenomics and Informatics Center center WashU Test Account Washington University Department of Neurology. Want to study Alzheimer, genetics, GWAS, X chromosome, multi-omics, and sex, APOE4, and ancestry effects? Join me! Ads in the thread.
Special thanks to our close collaborators Nir Barzilai Sofiya Milman 🎗️ at Albert Einstein College of Medicine - Official, Carlos Cruchaga lab at Knight ADRC, and Mormino Lab and Anthony Wagner at StanfordADRC. And Tobias Wüstefeld for the stunning Nature cover. 2/12
It was great to be part of this study by Hamilton Oh Jarod Rutledge, Ph.D. and Tony Wyss-Coray, where we contributed proteomics data from the Knight ADRC. Important findings that will help to understand aging processes
Multiple genes modify levels of sTREM2 and risk for #Alzheimer. In this study we integrated genetics and proteomics with functional genomics to identify novel genes implicated on disease pathogenesis Knight ADRC Washington University Department of Neurology SomaLogic …arneurodegeneration.biomedcentral.com/articles/10.11…
Interested in Single cell and Multiomics? Register for the NanoCourse! Offered by the experts Dennis Goldfarb, MollahLab, Tristan Qingyun Li, Guoyan Zhao. Learn genomics, proteomics, multiomics. Hands-on practice on data analysis and integration! @PapouinLab, neuroscienceresearch.wustl.edu/resources/nano…
Plasma proteomics identifies new biomarkers and predictive models for dystonia as well as specific dystonia presentations, and pinpoint to immune system, and reactive oxygen pathways to be implicated on disease. onlinelibrary.wiley.com/doi/10.1002/an… ANA Journals SomaLogic Washington University Department of Neurology
Molecular characterization of well phenotyped #Alzheimers cohorts will identify biomarkers and casual and druggable targets. In the Knight ADRC cohort we generated genetics, epigenetics, transcriptomics, proteomics and metabolomics in brain, CSF and blood. nature.com/articles/s4159…
We leverage human multi-omic data to identify causal and druggable targets and to create novel predictive models for #Alzheimers . Come to use the four talks and four posters at the #AAIC24. neurogenomics.wustl.edu/the-neurogenom…. Knight ADRC NeuroGenomics and Informatics Center Washington University Department of Neurology
Thomas Marsh, a @WUSTLdbbs student, just published his first manuscript looking the genetic architecture, predictive power and cross-tissue correlation of 11 #Alzheimers biomarkers and relevant proteins in CSF and plasma. #AAIC24 Knight ADRC alz-journals.onlinelibrary.wiley.com/doi/10.1002/al…